PAPER Kim YE, Jeon BS
SEARCH RESULTS
329938 RESULTS
PAPER Wang ZY, Lian H, Cai QQ, Song HY, Zhang XL, Zhou L, Zhang YM, Zheng LF, Zhu JX
No Direct Projection is Observed from the Substantia Nigra to the Dorsal Vagus Complex in the Rat.
J Parkinsons Dis. 2014 Mar 10; PubMed: 24613863PAPER Solje E, Hartikainen P, Valori M, Vanninen R, Tiihonen J, Hakola P, Tienari PJ, Remes AM
The C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation.
Neurobiol Aging. 2014 Jul;35(7):1780.e13-7. Epub 2014 Feb 5 PubMed: 24612676PAPER Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D
Prodromal features for Parkinson's disease--baseline data from the TREND study.
Eur J Neurol. 2014 May;21(5):766-72. Epub 2014 Feb 24 PubMed: 24612314PAPER Rodrigues TM, Jerónimo-Santos A, Outeiro TF, Sebastião AM, Diógenes MJ
Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.
Drugs Aging. 2014 Apr;31(4):239-61. PubMed: 24610720PAPER Pérez-H J, Carrillo-S C, García E, Ruiz-Mar G, Pérez-Tamayo R, Chavarría A
Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Toxicology. 2014 May 7;319:38-43. Epub 2014 Mar 4 PubMed: 24607817PAPER Noh H, Jeon J, Seo H
Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brain.
Neurochem Int. 2014 Apr;69:35-40. Epub 2014 Mar 7 PubMed: 24607701PAPER Finberg JP
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release.
Pharmacol Ther. 2014 Aug;143(2):133-152. Epub 2014 Mar 5 PubMed: 24607445PAPER Yadav A, Agrawal S, Tiwari SK, Chaturvedi RK
Mitochondria: Prospective Targets for Neuroprotection in Parkinson's Disease.
Curr Pharm Des. 2014 Mar 5; PubMed: 24606805PAPER Fidaleo M, Fanelli F, Ceru MP, Moreno S
Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands.
Curr Med Chem. 2014 Mar 3; PubMed: 24606520PAPER Urbizu A, Canet-Pons J, Munoz-Marmol AM, Aldecoa I, Lopez MT, Compta Y, Alvarez R, Ispierto L, Tolosa E, Ariza A, Beyer K
Cystatin C is differentially involved in multiple system atrophy phenotypes.
Neuropathol Appl Neurobiol. 2014 Mar 10; PubMed: 24606172PAPER Olanow CW
Do prions cause Parkinson disease?: the evidence accumulates.
Ann Neurol. 2014 Mar;75(3):331-3. Epub 2014 Feb 24 PubMed: 24615832PAPER Wood H
Prion disease: Cerebrospinal fluid tau levels--a potential diagnostic biomarker for Creutzfeldt-Jakob disease.
Nat Rev Neurol. 2014 Apr;10(4):180. Epub 2014 Mar 11 PubMed: 24614517PAPER McCutcheon S, Langeveld JP, Tan BC, Gill AC, de Wolf C, Martin S, Gonzalez L, Alibhai J, Blanco AR, Campbell L, Hunter N, Houston EF
Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity.
PLoS One. 2014;9(3):e91143. Epub 2014 Mar 7 PubMed: 24608105PAPER Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ
Bone health in Parkinson's disease: a systematic review and meta-analysis.
J Neurol Neurosurg Psychiatry. 2014 Mar 21; PubMed: 24620034Current Filters
No filters selected